Literature DB >> 6721454

Lack of clinical benefit from naloxone in a dementia day hospital.

J J Panella, J P Blass.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6721454     DOI： 10.1002/ana.410150320

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  5 in total

1.  Reversal of scopolamine-induced amnesia of passive avoidance by pre- and post-training naloxone.

Authors:  D K Rush
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 2.  Critical review of clinical trials in senile dementia--II.

Authors:  J M Orgogozo; R Spiegel
Journal:  Postgrad Med J       Date:  1987-05       Impact factor: 2.401

3.  Improved recognition memory in monkeys following naloxone administration.

Authors:  T G Aigner; M Mishkin
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Effect of naltrexone on senile dementia of the Alzheimer type.

Authors:  B T Hyman; P J Eslinger; A R Damasio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-11       Impact factor: 10.154

Review 5.  Advances in the pharmacotherapy of Alzheimer's disease.

Authors:  J C Soares; S Gershon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.